PHIO - Phio Pharmaceuticals Corp
1.16
-0.010 -0.862%
Share volume: 328,399
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.17
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | 03-05-2026 | |
| Assets | ||||||||
| Total Assets | 6.853 M | 5.296 M | 5.865 M | 13.440 M | 11.301 M | 11.505 M | 21.487 M | |
| Current Assets | 6.848 M | 5.292 M | 5.864 M | 13.436 M | 11.294 M | 11.493 M | 21.476 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.475 M | 4.698 M | 5.390 M | 13.278 M | 10.775 M | 10.705 M | 21.031 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.000 K | 1.000 K | 1.000 K | 4.000 K | 7.000 K | 12.000 K | 11.000 K | |
| Other Assets | 3.000 K | 3.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 6.853 M | 5.296 M | 5.865 M | 13.440 M | 11.301 M | 11.505 M | 21.487 M | |
| Total liabilities | 1.249 M | 1.523 M | 919.000 K | 1.270 M | 1.206 M | 1.666 M | 1.340 M | |
| Total current liabilities | 1.249 M | 1.523 M | 919.000 K | 1.270 M | 1.206 M | 1.666 M | 1.340 M | |
| Accounts Payable | 320.000 K | 335.000 K | 184.000 K | 427.000 K | 235.000 K | 516.000 K | 435.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 5.604 M | 3.773 M | 4.946 M | 12.170 M | 10.095 M | 9.839 M | 20.147 M | |
| Common stock | 146.964 M | 146.979 M | 149.676 M | 160.295 M | 160.386 M | 162.522 M | 175.201 M | |
| Retained earnings | -141.360 M | -143.206 M | -144.730 M | -148.125 M | -150.291 M | -152.683 M | -155.054 M |